EoFlow

Seongnam-si, South Korea Founded: 2011 • Age: 15 yrs Acquired By Medtronic
A wearable disposable insulin patch for diabetes patients is developed.
Annual revenue - Latest available
Total funding - 1 rounds
Employees - Tracked headcount
Investors 2 Known backers
Products - Services tracked
Competitors 11 Brand Intelligence

About EoFlow

EoFlow is a company based in Seongnam-si (South Korea) founded in 2011 was acquired by Medtronic in May 2023. EoFlow operates in a competitive market with competitors including Dexcom, Livongo, One Drop, mySugr and Senseonics, among others.

  • Headquarter Seongnam-si, South Korea
  • Stage Public
  • Sectors
    Healthcare
    Technology
  • Phone
    Locked
  • Website
    Locked
Operational Areas
Healthcare → Healthcare Products & Supplies Unlock Sub-Sector Unlock Segment
Technology → Extended, Virtual & Augmented Reality Unlock Sub-Sector Unlock Segment
Healthcare → Health Technology & Digital Health Unlock Sub-Sector Unlock Segment
Key Metrics
  • Annual Revenue
    Not available
  • Net Profit
    Not available
  • EBITDA
    Not available
  • Latest Funding Round
    Not available
  • Investors
    Medtronic

    & 1 more

  • Employee Count
    Not available
  • Acquired by
    Medtronic

    (May 25, 2023)

Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • Full access to every database India & global coverage, advanced filters and rich profile details
  • Always-on access from your team account Single premium plan for everything you see on the portal

Funding Insights of EoFlow

Investors in EoFlow

EoFlow has secured backing from 2 investors, including venture fund and institutional investors. Prominent investors backing the company include Medtronic and LB Investment.

All
Venture Fund
Institutional
Investor Description Founded Year Domain Location
Growth-stage private equity investments are targeted across multiple sectors.
Locked Locked Locked
Medical equipment for treating over 30 chronic diseases is developed.
Locked Locked Locked
Premium access

Investor details for EoFlow

Investor domains, locations, round participation, and complete history require an active premium plan.

  • Investor domains
  • Investor locations
  • Funding rounds
  • Participation history

Verified entity values are shown only after access is granted.

Investments & Acquisitions by EoFlow

Investments
Premium access

Investment portfolio details for EoFlow

Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.

  • Portfolio identities
  • Transaction dates
  • Round details
  • Investment values

Verified entity values are shown only after access is granted.

Financial Statements - EoFlow

Premium access

Detailed financials for EoFlow

Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.

  • Historical revenue
  • Profit trends
  • Statement rows
  • Financial ratios

Verified entity values are shown only after access is granted.

Eoflow Comparisons

EoFlow Primary company
Description
A wearable disposable insulin patch for diabetes patients is...
Location
Seongnam-si, South Korea
Founded Year
2011
Annual Revenue
Not available
Net Profit
Not available
EBITDA
Not available
Employees
Not available
Premium access

Peer comparison for EoFlow

Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.

  • Named peers
  • Headcount comparison
  • Funding comparison
  • Operating benchmarks

Verified entity values are shown only after access is granted.

+
Add Comparison
Available on Premium

Competitors of EoFlow

EoFlow operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Dexcom, Livongo, One Drop, mySugr and Senseonics, among others.

Company Name Domain Founded year HQ Location Description
Locked Locked Locked
Wearable glucose monitoring patches are provided for real-time data tracking.
Locked Locked Locked
Provider of smart devices for diabetes management for patients and doctors
Locked Locked Locked
Provider of workforce healthcare solutions
Locked Locked Locked
Gamified apps for diabetes management and therapy are provided.
Locked Locked Locked
Implantable continuous glucose monitoring systems are provided for diabetes management.
Locked Locked Locked
Mobile-based diagnostics for diabetes prevention and management are provided.
Premium access

Detailed competitors of EoFlow

Competitor domains, locations, full profiles, and operating metrics require an active premium plan.

  • Domains and locations
  • Full company profiles
  • Operating metrics
  • Competitive positioning

Verified entity values are shown only after access is granted.

Latest news on Eoflow

Premium access

Complete news archive for EoFlow

Full article history, source details, and older brand coverage require an active premium plan.

  • Full article archive
  • Source and publication date
  • Older coverage
  • Brand-specific news history

Verified entity values are shown only after access is granted.

Frequently Asked Questions about EoFlow

EoFlow was founded in 2011 and raised its 1st funding round 6 years after it was founded.

EoFlow is headquartered in Seongnam-si, South Korea. It is registered at Seongnam-si, Gyeonggi-do, South Korea.

Jesse Kim is the current CEO of EoFlow.

Developer of a wearable disposable insulin patch for diabetes patients. The patch is entirely tubeless and can be worn on any part of the body. The patch uses a stainless steel needle to deliver the drug. The patch can be controlled by a handheld touch-screen controller unit. It also extracts data from the patch to provide the user with the convenience of managing and analyzing the data.

EoFlow's top competitors include Dexcom, Senseonics and One Drop.

EoFlow has 2 investors. Key investors include Medtronic, and LB Investment.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available